Causes of Different Types of Anaemia

Anaemia is a condition characterized by a decrease in the number of red blood cells or a decrease in the amount of haemoglobin in the blood. There are different types of anaemia, and each has its own causes. Here are some of the causes of different types of anaemia:

Impaired Vitamin B12 Absorption: Vitamin B12 deficiency is a potential consequence of ileal resection and Crohn’s disease. Vitamin B12 injections may be required. Vitamin B12 deficiency causes a macrocytic anaemia.

Impaired Iron Absorption: Iron deficiency causes a microcytic anaemia. Iron deficiency anaemia is multifactorial, with gastrointestinal (GI), malabsorption and gynaecological causes being the most common causes. Ileal resection is not associated with impaired iron absorption, but gastrectomy can be.

Chronic Bleeding after Surgery: Iron deficiency due to chronic blood loss causes a microcytic anaemia. Acute blood loss would cause a normocytic anaemia.

Haemolysis: Haemolysis is the abnormal destruction of red blood cells. It causes a normocytic anaemia.

Bacterial Infection: A bacterial infection is not a common cause of anaemia.

Renal Cell Carcinoma: Symptoms, Diagnosis, and Prognosis

Renal cell carcinoma is a type of kidney cancer that often presents with haematuria, loin pain, and a flank mass. However, other symptoms such as weight loss, fatigue, and pyrexia may also occur. In some cases, paraneoplastic symptoms like a raised ESR may be present. Diagnosis involves FBC to check for anaemia or polycythaemia. Left-sided varicocele may also occur due to tumour invasion of the left renal vein. Prognosis depends on the tumour stage at diagnosis, with a 5-year survival rate of 60-70% for tumours confined to the renal parenchyma, 15-35% for lymph node involvement, and only 5% for distant metastases. It is important to differentiate renal cell carcinoma from other conditions such as lymphoma, multiple myeloma, testicular carcinoma, and chronic urinary tract infection.

The patient’s anaemia is complex and could have multiple causes. The anaemia is microcytic/normocytic and is accompanied by normal ferritin levels and elevated TIBC. However, the patient also has polymyalgia rheumatica, an inflammatory disorder that can affect ferritin levels. Ferritin is an acute-phase reactant and can be elevated in inflammation, making it an unreliable measurement.

Iron-deficient anaemia typically presents as microcytic with high TIBC levels. The high TIBC is due to the body’s ability to transport iron despite low iron levels. Iron-deficient anaemia also has low ferritin levels, but this may not be the case in this patient due to their chronic inflammatory condition. Therefore, iron-deficient anaemia is the most likely diagnosis due to the high TIBC levels.

Anaemia of chronic disease is also normocytic but typically has low or normal TIBC levels. This is because iron is trapped in inflammatory tissue and not available for use, reducing the body’s ability to transport free iron.

B12 deficiency results in macrocytic anaemia, which is not the case in this patient. Haemolytic anaemia is a rare form of anaemia that results in normocytic anaemia and does not explain the abnormalities in iron studies seen in this patient.

Iron Studies: Understanding the Different Tests

Iron studies are a group of laboratory tests that help evaluate a person’s iron status. These tests include serum iron, total iron binding capacity (TIBC), transferrin, transferrin saturation, and ferritin. Serum iron measures the amount of iron in the blood, while TIBC measures the amount of iron that can bind to transferrin, a protein that transports iron in the blood. Transferrin saturation is calculated by dividing serum iron by TIBC, and it reflects the percentage of transferrin that is saturated with iron. Ferritin, on the other hand, is a protein that stores iron in the body, and its level in the blood can indicate the amount of iron stored in the body.

In iron deficiency anaemia (IDA), the levels of serum iron and transferrin saturation are low, while TIBC and transferrin are high. Ferritin levels are also low in IDA. However, in pregnancy and in the presence of oestrogen, transferrin levels may be elevated. Inflammatory disorders, on the other hand, can cause an increase in ferritin levels.

Other rarer tests that may be used to evaluate iron status include transferrin receptors, which are increased in IDA, and tests for anaemia of chronic disease, which is a normochromic/hypochromic, normocytic anaemia characterized by reduced serum and TIBC levels and normal or raised ferritin levels. Understanding these different tests can help healthcare providers diagnose and manage iron-related disorders.

Small-cell carcinoma of the lung (SCLC) is a type of lung cancer that is often associated with a condition called syndrome of inappropriate antidiuretic hormone syndrome (SIADH). SIADH is caused by the abnormal release of anti-diuretic hormone (ADH), which leads to impaired water excretion and hyponatremia. This can result in symptoms such as nausea, weakness, confusion, and seizures. While SCLC is the most common cause of SIADH, it can also be caused by other types of cancer, certain drugs, intracranial lesions, and infections. Squamous-cell carcinoma (SCC) of the lung, on the other hand, does not typically result in SIADH as it does not originate from neuroendocrine cells. Pancreatic cancer can also cause SIADH, but it is less common than in SCLC. Prostate cancer, which is the second most common cancer globally, does not usually present with hormonal effects but rather with lower urinary tract symptoms. Bronchial carcinoid tumors, which are neuroendocrine tumors of the lung, can cause hormonal effects such as weight gain, high blood pressure, and hirsutism, but these symptoms are not indicated in the scenario given.

Rouleaux formation is a characteristic finding in multiple myeloma, which is a condition that presents with symptoms such as hypercalcaemia, anaemia, and back pain. Diagnosis of myeloma involves urine protein electrophoresis and serum-free light-chain assay. Rouleaux formation is observed as stacked RBCs on a blood film, resulting from an increase in acute-phase proteins that are positively charged and attract negatively charged RBCs. It is important to note that rouleaux formation is not exclusive to myeloma and can be seen in various inflammatory conditions. The erythrocyte sedimentation rate blood test measures this mechanism clinically. Heinz bodies, which are caused by oxidative stress and denaturation of haemoglobin, are not associated with myeloma but are seen in G6PD deficiency. Howell-Jolly bodies, which are present in hyposplenic or asplenic disorders, and an increased number of reticulocytes, which indicate increased RBC turnover, are also not characteristic of myeloma.

Understanding Multiple Myeloma: Features and Investigations

Multiple myeloma is a type of blood cancer that occurs due to genetic mutations in plasma cells. It is commonly diagnosed in individuals over the age of 70. The disease is characterized by the acronym CRABBI, which stands for Calcium, Renal, Anaemia, Bleeding, Bones, and Infection. Patients with multiple myeloma may experience hypercalcemia, renal damage, anaemia, bleeding, bone pain, and increased susceptibility to infections. Other symptoms may include amyloidosis, carpal tunnel syndrome, neuropathy, and hyperviscosity.

To diagnose multiple myeloma, doctors may perform a variety of tests, including blood tests, protein electrophoresis, bone marrow aspiration, and imaging studies. Blood tests may reveal anaemia, elevated levels of M protein in the blood or urine, and renal failure. Protein electrophoresis can detect raised concentrations of monoclonal IgA/IgG proteins in the serum or urine. Bone marrow aspiration confirms the diagnosis if the number of plasma cells is significantly raised. Imaging studies, such as whole-body MRI or X-rays, can detect osteolytic lesions or the characteristic rain-drop skull pattern.

The diagnostic criteria for multiple myeloma require one major and one minor criteria or three minor criteria in an individual who has signs or symptoms of the disease. Major criteria include plasmacytoma, 30% plasma cells in a bone marrow sample, and elevated levels of M protein in the blood or urine. Minor criteria include 10% to 30% plasma cells in a bone marrow sample, minor elevations in the level of M protein in the blood or urine, osteolytic lesions, and low levels of antibodies not produced by the cancer cells in the blood.

If a woman over the age of 30 presents with an unexplained breast lump, it is important to refer her urgently to the breast team using a suspected cancer pathway referral. It is important to inform the patient that they are being referred to a cancer service, but also explain that not all referrals to cancer services result in a cancer diagnosis. It is incorrect to perform a biopsy as an initial investigation, as this will be done in secondary care. While fibroadenoma is a common cause of breast lumps in young women, urgent referral to the breast team is necessary to rule out cancer in patients over 30 years old. It is not appropriate to schedule a GP review in 2 weeks, as this lump needs prompt investigation by the breast team.

In 2015, NICE released guidelines for referring individuals suspected of having breast cancer. If a person is 30 years or older and has an unexplained breast lump with or without pain, or if they are 50 years or older and have discharge, retraction, or other concerning changes in one nipple only, they should be referred using a suspected cancer pathway referral for an appointment within two weeks. If a person has skin changes that suggest breast cancer or is 30 years or older with an unexplained lump in the axilla, a suspected cancer pathway referral should also be considered. For individuals under 30 years old with an unexplained breast lump with or without pain, non-urgent referral should be considered.

Types of Leukaemia: Characteristics and Symptoms

Leukaemia is a type of cancer that affects the blood and bone marrow. There are different types of leukaemia, each with its own characteristics and symptoms. Here are some of the most common types:

Acute lymphoblastic leukaemia (ALL): This is the most common type of leukaemia in children, usually presenting before the age of five. It is associated with a clonal expansion of immature lymphoid progenitor cells, leading to anaemia, thrombocytopenia, and increased susceptibility to infections. Symptoms include hepatosplenomegaly, generalised lymphadenopathy, new-onset bruising, fatigue, joint and bone pain, bleeding, and superimposed infections. Treatment is with pegaspargase.

Hairy-cell leukaemia: This is a B-cell leukaemia usually affecting middle-aged men. The malignant cells have cytoplasmic projections that make them look hairy, hence the name.

Acute myeloblastic leukaemia (AML): This is a type of leukaemia that is most commonly seen in adults. It can be of various types, but one that is commonly assessed is promyelocytic leukaemia M3 that is characterised by cells with dark, pink, needle-like intracytoplasmic inclusions called Auer rods. This is a very aggressive form of leukaemia.

Chronic lymphocytic leukemia (CLL): This is a disease most commonly seen in the elderly and is usually of B-cell origin. Blood smear findings commonly refer to ‘smudge cells’, which is a result of the fragile cells breaking during preparation of the smear.

Chronic myelogenous leukemia (CML): This is a disease most commonly seen in middle-aged adults and is associated with the Philadelphia chromosome, a chimeric chromosome formed by the translocation of part of chromosome 9 to chromosome 22.

In conclusion, leukaemia is a serious disease that requires prompt diagnosis and treatment. Knowing the characteristics and symptoms of each type can help in early detection and management.

Understanding Mesothelioma and Other Possible Malignancies

Mesothelioma is a rare and aggressive form of cancer that is often linked to asbestos exposure. Those who worked as pipe laggers in the past were frequently exposed to asbestos, which can lead to mesothelioma. Symptoms of mesothelioma include cough, shortness of breath, chest pain, and weight loss. While the prognosis for mesothelioma remains poor, some cases can be surgically resected and chemotherapy can provide palliative care.

However, other malignancies can also present with similar symptoms, such as non-small-cell cancer, small-cell lung cancer, squamous-cell lung cancer, and bronchial carcinoid tumors. It is important to exclude these possibilities and properly diagnose the specific type of cancer in order to provide the most effective treatment.

Differential diagnosis for lymphocytosis in an elderly patient with vague symptoms

Chronic lymphocytic leukaemia (CLL) is the most likely cause of lymphocytosis in an elderly patient who presents with vague symptoms such as weight loss, night sweats and fatigue for six weeks. CLL is one of the most common types of leukaemia in adults, typically occurring during or after middle age and rarely in children.

Other possible diagnoses can be ruled out based on additional clinical features. Patients with HIV tend to have lymphopenia, not lymphocytosis. Lymphomas usually present with an enlargement of a lymph node, which is not reported in this case. Patients with polymyalgia rheumatica tend to have a normal leukocyte count, with some cases having increased estimated sedimentation rate and/or C-reactive protein. A transient viral illness would be an unlikely cause of lymphocytosis in an elderly person with persistent symptoms.

Therefore, CLL should be considered as the most likely diagnosis in this case, and further tests such as flow cytometry and bone marrow biopsy may be needed to confirm the diagnosis and determine the stage of the disease. Treatment options for CLL depend on the stage and other factors such as age and overall health, and may include watchful waiting, chemotherapy, immunotherapy, or targeted therapy.

To address her iron-deficiency anaemia, the patient should consume more foods rich in vitamin C and iron. Vitamin C can increase iron absorption by up to 10 times and maintain iron in its ferrous form. However, she should avoid breakfast cereals and white breads as they are often fortified with iron. Tea should also be avoided during meals or when taking iron supplements as it contains tannin, which reduces iron absorption. While a vegetarian diet can still provide non-haem iron, it is important to consume a variety of iron-rich plant-based foods. A gluten-free diet is only necessary if coeliac disease is present, which is unlikely in this case as the patient’s iron-deficiency anaemia is likely due to menorrhagia.

Differential diagnosis of spinal cord-related symptoms in cancer patients

Spinal cord-related symptoms can be a medical emergency in cancer patients, requiring prompt diagnosis and treatment. Several conditions can cause similar symptoms, including spinal cord compression, spinal tuberculosis, peripheral neuropathy secondary to carcinomatosis, paraneoplastic myelopathy, and secondary spinal tumor deposit.

Spinal cord compression is a common complication of metastatic cancer, especially from breast, bronchus, prostate, multiple myeloma, and high-grade non-Hodgkin’s lymphoma. The classic triad of symptoms includes bilateral leg weakness, sensory loss, and bladder/bowel dysfunction, but back pain may be absent or delayed. Imaging studies, such as plain radiographs and MRI, are essential for diagnosis, and treatment options include steroids, neurosurgery, and radiotherapy.

Spinal tuberculosis is a rare but serious infection that can affect the spine and cause bone or joint pain, back pain, or swelling. It usually requires a combination of antibiotics and surgery to cure.

Peripheral neuropathy secondary to carcinomatosis is a gradual and often mild onset of nerve damage caused by cancer cells or cancer treatments. It can present with various sensory, motor, or autonomic symptoms, depending on the location and extent of nerve involvement.

Paraneoplastic myelopathy is a rare but potentially severe neurological disorder that can occur in some cancer patients, especially those with small-cell or squamous cell lung cancer. It is caused by an abnormal immune response to cancer cells, leading to inflammation and damage to the spinal cord.

Secondary spinal tumor deposit is a less common cause of spinal cord-related symptoms than spinal cord compression, but it can also occur in cancer patients with metastatic disease. It may present with similar symptoms and require similar diagnostic and therapeutic approaches.

In summary, cancer patients with spinal cord-related symptoms should undergo a thorough evaluation to determine the underlying cause and appropriate management. Early recognition and treatment can improve outcomes and quality of life.

A finding of Auer rods on a blood film strongly indicates the presence of acute promyelocytic leukemia.

The correct answer is ‘Auer rods’. This patient has been diagnosed with APML, and the most common finding on a blood film associated with this is Auer rods. These are needle-like structures that are large, pink or red stained and can be seen within the cytoplasm of myeloid blast cells.

‘Tear-drop’ poikilocytes are typically found in myelofibrosis, which is characterized by flat, elongated red blood cells that resemble a tear-drop in shape. This occurs due to the squeezing of cells through fibrotic tissue in bone marrow in myelofibrotic disorders.

Smear cells are usually seen in chronic lymphocytic leukemia (CLL), which are remnants of cells that lack identifiable plasma membrane or nuclear structure.

Spherocytes are generally found in hereditary spherocytosis or autoimmune hemolytic anemia, which are red blood cells that are sphere-shaped and more fragile than normal red blood cells due to abnormalities in the red cell membrane.

Acute myeloid leukaemia is a common form of acute leukaemia in adults that may occur as a primary disease or following a myeloproliferative disorder. Symptoms are related to bone marrow failure and include anaemia, neutropenia, thrombocytopenia, splenomegaly, and bone pain. Poor prognostic features include age over 60, >20% blasts after first course of chemo, and deletions of chromosome 5 or 7. Acute promyelocytic leukaemia M3 is associated with t(15;17) and has a good prognosis. The French-American-British classification system includes seven subtypes.

In this scenario, the BNF suggests administering half of the oral dose of morphine when using the parenteral route (subcutaneous, intramuscular, or intravenous). If the patient is no longer able to swallow, a continuous subcutaneous infusion of morphine is typically given.

Palliative care prescribing for pain is guided by NICE and SIGN guidelines. NICE recommends starting treatment with regular oral modified-release or immediate-release morphine, with immediate-release morphine for breakthrough pain. Laxatives should be prescribed for all patients initiating strong opioids, and antiemetics should be offered if nausea persists. Drowsiness is usually transient, but if it persists, the dose should be adjusted. SIGN advises that the breakthrough dose of morphine is one-sixth the daily dose, and all patients receiving opioids should be prescribed a laxative. Opioids should be used with caution in patients with chronic kidney disease, and oxycodone is preferred to morphine in patients with mild-moderate renal impairment. Metastatic bone pain may respond to strong opioids, bisphosphonates, or radiotherapy, and all patients should be considered for referral to a clinical oncologist for further treatment. When increasing the dose of opioids, the next dose should be increased by 30-50%. Conversion factors between opioids are also provided. Opioid side-effects are usually transient, such as nausea and drowsiness, but constipation can persist. In addition to strong opioids, bisphosphonates, and radiotherapy, denosumab may be used to treat metastatic bone pain.

Overall, the guidelines recommend starting with regular oral morphine and adjusting the dose as needed. Laxatives should be prescribed to prevent constipation, and antiemetics may be needed for nausea. Opioids should be used with caution in patients with chronic kidney disease, and oxycodone is preferred in patients with mild-moderate renal impairment. Metastatic bone pain may respond to strong opioids, bisphosphonates, or radiotherapy, and referral to a clinical oncologist should be considered. Conversion factors between opioids are provided, and the next dose should be increased by 30-50% when adjusting the dose. Opioid side-effects are usually transient, but constipation can persist. Denosumab may also be used to treat metastatic bone pain.

The patient’s history and blood results suggest that they have chronic myeloid leukaemia (CML), which is characterized by a high white cell count due to an excess of myeloid cells and a chronic presentation. The absence of blast cells indicates that this is not acute leukaemia. The patient’s anaemia and thrombocytopenia are likely due to bone marrow dysfunction caused by myelofibrosis, indicating a need for treatment. The first-line treatment for CML is imatinib, a tyrosine kinase inhibitor that is taken as a daily tablet and has shown excellent results in treating CML.

Given the patient’s signs of bone marrow dysfunction, conservative management is not appropriate. While there may be a role for no treatment in early disease detected incidentally on a blood test, this patient requires treatment at this point.

It is important to note that fludarabine and cyclophosphamide are chemotherapy agents used in treating chronic lymphocytic leukaemia (CLL) and have no role in managing CML. The blood test abnormalities expected in CLL are similar to those seen in CML, but with a differential showing normal or low neutrophil and high lymphocyte counts.

Prednisolone, a glucocorticoid used to treat various conditions, is often used in treating different forms of lymphoma but is not effective in managing CML.

Understanding Chronic Myeloid Leukaemia and its Management

Chronic myeloid leukaemia (CML) is a type of cancer that affects the blood and bone marrow. It is characterized by the presence of the Philadelphia chromosome in more than 95% of patients. This chromosome is formed due to a translocation between chromosomes 9 and 22, resulting in the fusion of the ABL proto-oncogene and the BCR gene. The resulting BCR-ABL gene produces a fusion protein that has excessive tyrosine kinase activity.

CML typically affects individuals between 60-70 years of age and presents with symptoms such as anaemia, weight loss, sweating, and splenomegaly. The condition is also associated with an increase in granulocytes at different stages of maturation and thrombocytosis. In some cases, CML may undergo blast transformation, leading to acute myeloid leukaemia (AML) or acute lymphoblastic leukaemia (ALL).

The management of CML involves various treatment options, including imatinib, which is considered the first-line treatment. Imatinib is an inhibitor of the tyrosine kinase associated with the BCR-ABL defect and has a very high response rate in the chronic phase of CML. Other treatment options include hydroxyurea, interferon-alpha, and allogenic bone marrow transplant. With proper management, individuals with CML can lead a normal life.

When a woman presents with a breast lump, fat necrosis should be considered as a possible diagnosis if there is a history of trauma to the area. This condition typically presents as a firm lump that may be accompanied by bruising. Fibroadenomas, on the other hand, are more commonly seen in younger women and present as a mobile but firm lump that can be easily moved during examination. Breast cysts are fluid-filled masses that may be detected if they are large enough and can fluctuate or transilluminate. Breast abscesses are typically seen in breastfeeding women and present as a hot, tender swelling. While breast cancer is unlikely based on the clinical history, all women with a breast lump should be referred to a specialist for confirmation of diagnosis through triple assessment. It is important to note that intentional weight loss, as in this case, should not be considered a factor in the diagnosis.

Understanding Fat Necrosis of the Breast

Fat necrosis of the breast is a condition that affects up to 40% of cases and is often caused by trauma. This condition can be mistaken for breast cancer due to its physical features, such as a mass that may initially increase in size. It is important to understand that fat necrosis is not cancerous and can be treated with proper care.

Prognostic Factors in Breast Cancer and Their Impact on Survival

Breast cancer prognosis is influenced by several factors, including axillary nodal status, tumour type and grade, lymphatic/vascular invasion/proliferation markers, ethnicity, patient age at diagnosis, oestrogen receptor and progesterone receptor status, and HER2/neu overexpression. Younger patients tend to have more aggressive tumours, which increases their risk of recurrence and mortality over their lifetimes.

Oestrogen receptor-positive tumours have a better prognosis and can be treated with tamoxifen, which increases survival rates. Progesterone receptor-positive tumours also have a good prognosis and can be targeted using HER2 receptor modulators like tamoxifen. On the other hand, oestrogen receptor-negative and progesterone receptor-negative tumours are associated with a poor prognosis.

Tumour grade is another important prognostic factor, with high-grade tumours being linked to a poorer prognosis. Additionally, a positive lymph node status is a poor prognostic factor, as the risk of recurrence increases with the number of affected nodes.

In summary, understanding these prognostic factors can help healthcare professionals tailor treatment plans and provide patients with more accurate information about their prognosis and survival.

A possible diagnosis for an older woman with a labial lump and inguinal lymphadenopathy is vulval carcinoma, especially if the lump is firm and has grown rapidly over a short period of time. Risk factors for this condition include advanced age, smoking, and HPV infection. Bartholin’s cyst, condylomata lata, lipoma, and sebaceous cyst are less likely diagnoses, as they do not typically present with the same symptoms or risk factors as vulval carcinoma.

Understanding Vulval Carcinoma

Vulval carcinoma is a type of cancer that affects the vulva, which is the external female genitalia. It is a relatively rare condition, with only around 1,200 cases diagnosed in the UK each year. The majority of cases occur in women over the age of 65 years, and around 80% of cases are squamous cell carcinomas.

There are several risk factors associated with vulval carcinoma, including human papilloma virus (HPV) infection, vulval intraepithelial neoplasia (VIN), immunosuppression, and lichen sclerosus. Symptoms of vulval carcinoma may include a lump or ulcer on the labia majora, inguinal lymphadenopathy, and itching or irritation.

It is important for women to be aware of the risk factors and symptoms of vulval carcinoma, and to seek medical attention if they experience any concerning symptoms. Early detection and treatment can improve outcomes and increase the chances of a full recovery.

Pulmonary fibrosis is a potential side effect of bleomycin, a cytotoxic antibiotic commonly prescribed for metastatic germ cell cancer, squamous cell carcinoma, and non-Hodgkin’s lymphoma. The severity of this adverse effect is directly proportional to the dosage administered.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin, degrade preformed DNA and can lead to lung fibrosis. Anthracyclines, such as doxorubicin, stabilize the DNA-topoisomerase II complex and inhibit DNA and RNA synthesis, but can also cause cardiomyopathy. Antimetabolites, like methotrexate, inhibit dihydrofolate reductase and thymidylate synthesis, leading to myelosuppression, mucositis, liver fibrosis, and lung fibrosis. Fluorouracil (5-FU) is a pyrimidine analogue that induces cell cycle arrest and apoptosis by blocking thymidylate synthase, but can also cause myelosuppression, mucositis, and dermatitis. Cytarabine is a pyrimidine antagonist that interferes with DNA synthesis specifically at the S-phase of the cell cycle and inhibits DNA polymerase, but can also cause myelosuppression and ataxia. Drugs that act on microtubules, like vincristine and vinblastine, inhibit the formation of microtubules and can cause peripheral neuropathy, paralytic ileus, and myelosuppression. Docetaxel prevents microtubule depolymerisation and disassembly, decreasing free tubulin, but can also cause neutropaenia. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I which prevents relaxation of supercoiled DNA, but can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin, cause cross-linking in DNA and can lead to ototoxicity, peripheral neuropathy, and hypomagnesaemia. Hydroxyurea (hydroxycarbamide) inhibits ribonucleotide reductase, decreasing DNA synthesis, but can also cause myelosuppression.

For cancer patients with VTE, the recommended treatment is a DOAC for a period of 6 months. Among the DOACs, apixaban is the most suitable option as it has been found to have a lower risk of bleeding complications compared to LMWH and VKA. Moreover, patients taking apixaban can benefit from oral treatment and avoid frequent monitoring required with other anticoagulation treatments. Studies have also shown that apixaban is the most cost-effective option as it results in fewer bleeds.

NICE updated their guidelines on the investigation and management of venous thromboembolism (VTE) in 2020. The use of direct oral anticoagulants (DOACs) is recommended as first-line treatment for most people with VTE, including as interim anticoagulants before a definite diagnosis is made. Routine cancer screening is no longer recommended following a VTE diagnosis. The cornerstone of VTE management is anticoagulant therapy, with DOACs being the preferred choice. All patients should have anticoagulation for at least 3 months, with the length of anticoagulation being determined by whether the VTE was provoked or unprovoked.

Understanding Radiation Enteritis and Other Possible Causes of Bowel Symptoms

Radiation enteritis is a condition that occurs when the bowel becomes inflamed due to radiation therapy. It can manifest as ileitis, colitis, or proctitis, and can be acute or chronic. Acute radiation enteritis typically occurs during therapy and presents with symptoms such as anorexia, diarrhoea, and abdominal pain. Chronic radiation enteritis, on the other hand, can develop months or years after treatment and may cause weight loss, steatorrhoea, and small bowel obstruction.

While radiation enteritis is a likely cause of bowel symptoms in patients who have undergone radiation therapy, other conditions should also be considered. Bowel obstruction, for example, can cause nausea, vomiting, and bloating, but does not typically cause diarrhoea. Local malignant infiltration to the bowel may present with obstruction, while bowel perforation is a medical emergency that causes peritonitis and sepsis.

In summary, understanding the possible causes of bowel symptoms is important in determining the appropriate treatment for patients. While radiation enteritis is a common consequence of radiation therapy, other conditions such as bowel obstruction, local malignant infiltration, and bowel perforation should also be considered.

Differentiating Leukaemia and Lymphoma: Characteristics and Symptoms

Leukaemia and lymphoma are both types of blood cancer, but they have distinct characteristics and symptoms. In this context, we will discuss the characteristics and symptoms of chronic lymphocytic leukaemia (CLL), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML), Hodgkin’s lymphoma (HL), and multiple myeloma (MM).

CLL is the most common leukaemia in adults, characterized by peripheral blood lymphocytosis and uncontrolled proliferation of B cell lymphocytes in the bone marrow, lymph nodes, and splenomegaly. Patients are often asymptomatic, and CLL is often picked up incidentally.

ALL is a common leukaemia of children aged 2–5 years and is very rare in adults.

CML tends to present with more systemic, B symptoms in a slightly younger age group. A classic symptom is a massive hepatosplenomegaly. Blood film would show PMNs, basophils, and myelocytes.

HL is a possibility in this age group; however, the question asks for the ‘most likely’ diagnosis, which would be CLL as it is more common in this age group and the western world. Further investigation would be used to confirm the diagnosis.

MM is the uncontrolled proliferation of plasma cells and does not present in the way described above. Bone pain, hypercalcaemia, renal failure, and neutropenia are common presentations.

A diagnosis of ITP is suggested by the presence of isolated thrombocytopenia in a healthy patient. Blood dyscrasias are not typically caused by the use of combined oral contraceptive pills.

Understanding Immune Thrombocytopenia (ITP) in Adults

Immune thrombocytopenia (ITP) is a condition where the immune system attacks and reduces the number of platelets in the blood. This is caused by antibodies targeting the glycoprotein IIb/IIIa or Ib-V-IX complex. While children with ITP usually experience acute thrombocytopenia after an infection or vaccination, adults tend to have a more chronic form of the condition. ITP is more common in older females and may be detected incidentally during routine blood tests. Symptoms may include petechiae, purpura, and bleeding, but catastrophic bleeding is not a common presentation.

To diagnose ITP, a full blood count and blood film are typically performed. While a bone marrow examination is no longer routinely used, antiplatelet antibody testing may be done, although it has poor sensitivity and does not affect clinical management. The first-line treatment for ITP is oral prednisolone, but pooled normal human immunoglobulin (IVIG) may also be used if active bleeding or an urgent invasive procedure is required. Splenectomy is now less commonly used as a treatment option.

In some cases, ITP may be associated with autoimmune haemolytic anaemia (AIHA), which is known as Evan’s syndrome. It is important for individuals with ITP to work closely with their healthcare provider to manage their condition and prevent complications.

Understanding Hodgkin’s Lymphoma: Symptoms and Prognosis Factors

Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system. One of the most common symptoms of this malignancy is painless, non-tender, asymmetrical lymphadenopathy. However, the presence of night sweats, fever, and weight loss can also indicate a diagnosis of Hodgkin’s lymphoma. Patients of Afro-Caribbean origin may have a worse prognosis in acute lymphoblastic leukaemia, but not in Hodgkin’s lymphoma. Alcohol-induced pain is a characteristic feature of some cases of Hodgkin’s lymphoma, but it has not been associated with a poor prognosis. Asymmetrical lymphadenopathy is a typical feature of Hodgkin’s lymphoma and has not been linked to a worse prognosis. Finally, while female sex has not been associated with poor prognosis, some studies suggest that male sex could be connected with a poorer outcome.

An aplastic crisis, often caused by parvovirus infection, is characterized by a sudden decrease in haemoglobin levels without a corresponding increase in reticulocytes.

Sickle cell anaemia is a condition that involves periods of good health with intermittent crises. There are several types of crises that can occur, including thrombotic or painful crises, sequestration, acute chest syndrome, aplastic, and haemolytic. Thrombotic crises, also known as painful crises or vaso-occlusive crises, are triggered by factors such as infection, dehydration, and deoxygenation. These crises are diagnosed clinically and can result in infarcts in various organs, including the bones, lungs, spleen, and brain.

Sequestration crises occur when sickling occurs within organs such as the spleen or lungs, leading to pooling of blood and worsening of anaemia. This type of crisis is associated with an increased reticulocyte count. Acute chest syndrome is caused by vaso-occlusion within the pulmonary microvasculature, resulting in infarction in the lung parenchyma. Symptoms include dyspnoea, chest pain, pulmonary infiltrates on chest x-ray, and low pO2. Management involves pain relief, respiratory support, antibiotics, and transfusion.

Aplastic crises are caused by infection with parvovirus and result in a sudden fall in haemoglobin. Bone marrow suppression leads to a reduced reticulocyte count. Haemolytic crises are rare and involve a fall in haemoglobin due to an increased rate of haemolysis. It is important to recognise and manage these crises promptly, as they can lead to serious complications and even death.

The Importance of Lymph Node Biopsy in Diagnosing Hodgkin’s Lymphoma

When it comes to diagnosing Hodgkin’s lymphoma, a lymph node biopsy is the most reliable method. Fine-needle aspiration should not be used as the sole method for diagnosis. In addition to the biopsy, a thorough evaluation should include a medical history and examination, blood tests, liver function tests, serum protein tests, HIV testing, chest radiograph, CT scans, and bone marrow biopsy. Gallium scans can also be performed to document radioisotope uptake by the tumor. Lymphangiography may be necessary if the presentation of Hodgkin’s lymphoma is subdiaphragmatic. While a raised ESR can indicate Hodgkin’s lymphoma, it is not the most important step in obtaining a diagnosis. Similarly, repeating a CRP test or blood cultures would not be appropriate if the initial results were negative. In summary, a lymph node biopsy is crucial in diagnosing Hodgkin’s lymphoma and should be the first step in the evaluation process.

Chronic myeloid leukaemia (CML) is a rare form of cancer that occurs due to the abnormal growth of myeloid precursors or blasts. This leads to an increase in white blood cells and a decrease in the normal functions of the bone marrow, resulting in anaemia and thrombocytopenia. CML is most commonly seen in people between the ages of 60 and 70 and has a slow onset that can last for months or even years. The majority of cases are caused by a genetic mutation called the Philadelphia chromosome, which produces a protein that promotes the growth of cancer cells. Symptoms of CML include fatigue, weight loss, night sweats, abdominal distension, and left upper quadrant pain. Treatment for CML involves inhibiting the genetic mutation with a drug called imatinib.

Acute lymphocytic leukaemia (ALL) is a type of cancer that occurs due to the abnormal growth of immature lymphocytes, which replace the normal cells of the bone marrow and lead to a decrease in blood cell production. ALL is most commonly seen in children and presents with symptoms such as anaemia, fever, and abdominal pain. Diagnosis is made through bone marrow biopsy and genetic analysis, which can reveal chromosomal abnormalities associated with the disease.

Hodgkin’s lymphoma (HL) is a type of cancer that typically presents with enlarged lymph nodes and is associated with the presence of Reed-Sternberg cells, which are abnormal B cells. Multiple myeloma (MM) is a cancer that affects plasma cells in the bone marrow, leading to a decrease in blood cell production and other symptoms such as hypercalcemia and kidney dysfunction. Non-Hodgkin’s lymphoma (NHL) is a type of cancer that arises from the abnormal growth of B cells, T cells, or natural killer cells and can be caused by genetic mutations, infections, or chronic inflammation. Symptoms of NHL include enlarged lymph nodes throughout the body.

Peripheral neuropathy is a known side effect of Vincristine. Additionally, bladder atony may cause urinary hesitancy.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin, degrade preformed DNA and can lead to lung fibrosis. Anthracyclines, such as doxorubicin, stabilize the DNA-topoisomerase II complex and inhibit DNA and RNA synthesis, but can also cause cardiomyopathy. Antimetabolites, like methotrexate, inhibit dihydrofolate reductase and thymidylate synthesis, leading to myelosuppression, mucositis, liver fibrosis, and lung fibrosis. Fluorouracil (5-FU) is a pyrimidine analogue that induces cell cycle arrest and apoptosis by blocking thymidylate synthase, but can also cause myelosuppression, mucositis, and dermatitis. Cytarabine is a pyrimidine antagonist that interferes with DNA synthesis specifically at the S-phase of the cell cycle and inhibits DNA polymerase, but can also cause myelosuppression and ataxia. Drugs that act on microtubules, like vincristine and vinblastine, inhibit the formation of microtubules and can cause peripheral neuropathy, paralytic ileus, and myelosuppression. Docetaxel prevents microtubule depolymerisation and disassembly, decreasing free tubulin, but can also cause neutropaenia. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I which prevents relaxation of supercoiled DNA, but can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin, cause cross-linking in DNA and can lead to ototoxicity, peripheral neuropathy, and hypomagnesaemia. Hydroxyurea (hydroxycarbamide) inhibits ribonucleotide reductase, decreasing DNA synthesis, but can also cause myelosuppression.

Tumour lysis syndrome is characterized by high levels of potassium and phosphate, as well as low levels of calcium. This is evident in the case history of a lymphoma patient who has started chemotherapy. Allopurinol is the most commonly used prophylaxis, with rasburicase as an alternative. Diuretics are not recommended due to the potential to exacerbate acute kidney injury. It is important to note that steroids and radiotherapy are not common causes of tumour lysis syndrome.

Understanding Tumour Lysis Syndrome

Tumour lysis syndrome (TLS) is a life-threatening condition that can occur during the treatment of high-grade lymphomas and leukaemias. Although it can happen without chemotherapy, it is usually triggered by the introduction of combination chemotherapy. Patients at high risk of TLS should be given prophylactic medication such as IV allopurinol or IV rasburicase to prevent the potentially deadly effects of tumour cell lysis. Rasburicase is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin, which is more easily excreted by the kidneys. Patients in lower-risk groups should be given oral allopurinol during chemotherapy cycles to avoid the condition. However, rasburicase and allopurinol should not be given together in the management of tumour lysis syndrome as this reduces the effect of rasburicase.

TLS occurs when tumour cells break down and release chemicals into the body, leading to high levels of potassium and phosphate and a low level of calcium. It should be suspected in any patient presenting with an acute kidney injury in the presence of high phosphate and uric acid levels. From 2004, TLS has been graded using the Cairo-Bishop scoring system, which considers abnormality in two or more of the following within three days before or seven days after chemotherapy: uric acid, potassium, phosphate, and calcium. Clinical tumour lysis syndrome is when laboratory tumour lysis syndrome is present along with increased serum creatinine, cardiac arrhythmia or sudden death, or seizure.

In summary, understanding tumour lysis syndrome is critical in the treatment of high-grade lymphomas and leukaemias. Prophylactic medication can be given to prevent the potentially deadly effects of tumour cell lysis, and the Cairo-Bishop scoring system can be used to grade the severity of the condition. Early detection and management of TLS can improve patient outcomes and prevent complications.

Cardiomyopathy can be caused by anthracyclines such as doxorubicin.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin, degrade preformed DNA and can lead to lung fibrosis. Anthracyclines, such as doxorubicin, stabilize the DNA-topoisomerase II complex and inhibit DNA and RNA synthesis, but can also cause cardiomyopathy. Antimetabolites, like methotrexate, inhibit dihydrofolate reductase and thymidylate synthesis, leading to myelosuppression, mucositis, liver fibrosis, and lung fibrosis. Fluorouracil (5-FU) is a pyrimidine analogue that induces cell cycle arrest and apoptosis by blocking thymidylate synthase, but can also cause myelosuppression, mucositis, and dermatitis. Cytarabine is a pyrimidine antagonist that interferes with DNA synthesis specifically at the S-phase of the cell cycle and inhibits DNA polymerase, but can also cause myelosuppression and ataxia. Drugs that act on microtubules, like vincristine and vinblastine, inhibit the formation of microtubules and can cause peripheral neuropathy, paralytic ileus, and myelosuppression. Docetaxel prevents microtubule depolymerisation and disassembly, decreasing free tubulin, but can also cause neutropaenia. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I which prevents relaxation of supercoiled DNA, but can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin, cause cross-linking in DNA and can lead to ototoxicity, peripheral neuropathy, and hypomagnesaemia. Hydroxyurea (hydroxycarbamide) inhibits ribonucleotide reductase, decreasing DNA synthesis, but can also cause myelosuppression.

Metastasis Patterns of Common Carcinomas

Carcinomas are malignant tumors that can spread to other parts of the body through a process called metastasis. The patterns of metastasis vary depending on the type of carcinoma. Here are some common carcinomas and their typical metastasis patterns:

Bronchial Carcinoma: This type of carcinoma often spreads to the bone or brain. Symptoms may include difficulty breathing, coughing, chest pain, weight loss, and fatigue.

Brain Carcinoma: Primary malignant brain tumors rarely spread to other parts of the body, but they can spread to surrounding areas of the brain and spinal cord.

Renal Carcinoma: Renal cancers commonly metastasize to the lungs, producing lesions that appear like cannonballs on a chest X-ray. They can also spread to the bone, causing osteolytic lesions.

Gastric Carcinoma: Gastric cancers tend to spread to the liver, lung, and peritoneum. Tumors that have a preference for bone metastasis include those of the lung, prostate, breast, kidney, and thyroid.

Colorectal Carcinoma: Colorectal cancers commonly metastasize to the liver, lung, and peritoneum. Tumors that have a preference for bone metastasis include those of the lung, prostate, breast, kidney, and thyroid.

Understanding the patterns of metastasis for different types of carcinomas can help with early detection and treatment. If you experience any symptoms or have concerns, it’s important to speak with your healthcare provider.